gadopiclenol (Elucirem) Report issue

Small molecule Imaging Approved FDA Priority Review FDA

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

  • Mechanisms of Action:
  • Multi-specific: Missing data
  • Black Box: Yes
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Organizations (5)

Research & Development (5)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (7)

Approved Indications (1)


 

Vascular Diseases (approved 2022)

Experimental Indications - Clinical Trial Phases 1-4 (6)


 

Brain Diseases (Phase 3)

Brain Neoplasms (Phase 3)

Central Nervous System Diseases (Phase 3)

Endomyocardial Fibrosis (Phase 4)

Fasting (Phase 2)

Pharmacokinetics (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial Organizations: 5

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue